Tactile Systems Technology Inc
NASDAQ:TCMD
Tactile Systems Technology Inc
Revenue
Tactile Systems Technology Inc
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Tactile Systems Technology Inc
NASDAQ:TCMD
|
Revenue
$293m
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
20%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$20.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$17.6B
|
CAGR 3-Years
13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$22.6B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$42.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$8.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
Tactile Systems Technology Inc
Revenue Breakdown
Breakdown by Geography
Tactile Systems Technology Inc
Breakdown by Segments
Tactile Systems Technology Inc
|
Total Revenue:
293m
USD
|
|
Represents Information Pertaining To Lymphede...:
259.4m
USD
|
|
Sales Revenue:
256m
USD
|
|
Information Relating To Rental Product Servic...:
37m
USD
|
Tactile Systems Technology Inc
Glance View
Tactile Systems Technology, Inc. is a medical technology company. The company is headquartered in Minneapolis, Minnesota and currently employs 988 full-time employees. The company went IPO on 2016-07-28. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. The company is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.
See Also
What is Tactile Systems Technology Inc's Revenue?
Revenue
293m
USD
Based on the financial report for Dec 31, 2024, Tactile Systems Technology Inc's Revenue amounts to 293m USD.
What is Tactile Systems Technology Inc's Revenue growth rate?
Revenue CAGR 10Y
20%
Over the last year, the Revenue growth was 7%. The average annual Revenue growth rates for Tactile Systems Technology Inc have been 12% over the past three years , 9% over the past five years , and 20% over the past ten years .
You don't have any saved screeners yet